Free Trial
NASDAQ:ACCD

Accolade (ACCD) Stock Price, News & Analysis

Accolade logo
$3.45 -0.03 (-0.86%)
(As of 05:45 PM ET)

About Accolade Stock (NASDAQ:ACCD)

Key Stats

Today's Range
$3.34
$3.49
50-Day Range
$3.15
$3.86
52-Week Range
$3.08
$15.36
Volume
632,778 shs
Average Volume
1.09 million shs
Market Capitalization
$277.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.96
Consensus Rating
Moderate Buy

Company Overview

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Accolade Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
97th Percentile Overall Score

ACCD MarketRank™: 

Accolade scored higher than 97% of companies evaluated by MarketBeat, and ranked 17th out of 332 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Accolade has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 11 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Accolade has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Accolade's stock forecast and price target.
  • Earnings Growth

    Earnings for Accolade are expected to grow in the coming year, from ($0.92) to ($0.87) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Accolade is -3.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Accolade is -3.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Accolade has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.90% of the outstanding shares of Accolade have been sold short.
  • Short Interest Ratio / Days to Cover

    Accolade has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accolade has recently decreased by 13.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Accolade does not currently pay a dividend.

  • Dividend Growth

    Accolade does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.90% of the outstanding shares of Accolade have been sold short.
  • Short Interest Ratio / Days to Cover

    Accolade has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Accolade has recently decreased by 13.74%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Accolade has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Accolade this week, compared to 3 articles on an average week.
  • Search Interest

    Only 3 people have searched for ACCD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Accolade to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Accolade insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $150,475.00 in company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Accolade is held by insiders.

  • Percentage Held by Institutions

    84.99% of the stock of Accolade is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Accolade's insider trading history.
Receive ACCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

ACCD Stock News Headlines

Reviewing Sezzle (NASDAQ:SEZL) & Accolade (NASDAQ:ACCD)
A Simple Trading Strategy You Should Know
It’s no secret, I love big, juicy options trades. But when you’re chasing the BIG fish, you gotta have a way to target some steady, consistent returns in there as well. Check out the $100 Challenge This Chris Pulver, he’s isolated a way for everyday folks to target $100-$150 a day in the stock market, starting with just $1,000 or so. And while we cannot promise future returns or against losses, It’s the perfect supplement to more aggressive options strategies… And right now, everyone needs more cash in this economy.
Accolade price target lowered to $5 from $6 at Morgan Stanley
Short Interest in Accolade, Inc. (NASDAQ:ACCD) Decreases By 13.7%
See More Headlines

ACCD Stock Analysis - Frequently Asked Questions

Accolade's stock was trading at $12.01 on January 1st, 2024. Since then, ACCD stock has decreased by 71.3% and is now trading at $3.45.
View the best growth stocks for 2024 here
.

Accolade, Inc. (NASDAQ:ACCD) posted its quarterly earnings results on Tuesday, October, 8th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.14. The firm's revenue was up 9.8% compared to the same quarter last year.

Accolade (ACCD) raised $176 million in an IPO on Thursday, July 2nd 2020. The company issued 8,800,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

Top institutional investors of Accolade include ARK Investment Management LLC (6.68%), State Street Corp (2.39%), Sumitomo Mitsui Trust Group Inc. (2.35%) and Geode Capital Management LLC (2.21%). Insiders that own company stock include Stephen H Barnes, Robert N Cavanaugh, Michael W Hilton, Richard Eskew and Colin Mchugh.
View institutional ownership trends
.

Shares of ACCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Accolade investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), Humana (HUM), The RMR Group (RMR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
10/08/2024
Today
12/23/2024
Fiscal Year End
2/28/2025

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:ACCD
Fax
N/A
Employees
2,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.96
High Stock Price Target
$16.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+159.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
14 Analysts

Profitability

Net Income
$-99,810,000.00
Pretax Margin
-17.76%

Debt

Sales & Book Value

Annual Sales
$441.03 million
Book Value
$5.75 per share

Miscellaneous

Free Float
73,933,000
Market Cap
$277.85 million
Optionable
Optionable
Beta
2.07

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ACCD) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners